New clinical trials from Rockefeller University researchers suggest that a combination of two anti-HIV antibodies is capable of suppressing HIV for months.
Natural antibodies recognize a single target on a foreign protein. In this study, antibodies were engineered to recognize three different target sites in one molecule.